Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina

/ 2024, CIESP, Health Technology Assessment, Scientific Publications

Espinola N, Secco A, Balan D, Kanevsky D, Calvi G, Morisset P, et al. Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina. Rev Peru Med Exp Public Health. 2024;41(2):129-39.

Go to publication